Optimizing Pain Control in Transurethral Resection of the Prostate

NCT ID: NCT04102566

Last Updated: 2019-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-08

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators believe this is an important step in reducing the opioid epidemic in surgical patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In our study, the investigators will randomize TURP patients to standard of care versus a multi-modal protocol. Multi-modal pain control is defined as: "analgesia that combines 2 or more agents that act by different mechanisms to provide analgesia with better pain relief and less opioids". In addition, patients in the intervention arm will receive education regarding pain control and opioid use. The investigators aim to demonstrate non-inferior pain control with this approach. The investigators hope this will inform new guidelines for pain control after TURP, minimize opioid use in this patient population, and educate physicians and patients on providing excellent pain control while minimizing the risks of opioid use. The investigators believe this could ultimately serve as a model for other endoscopic urologic procedures as well.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain BPH With Urinary Obstruction BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard of care arm

The standard of care group will group will receive the following regimen while inpatient:

* 2% topical lidocaine gel applied to catheter tip as needed for pain, maximum dose of 600mg in 12 hours
* Acetaminophen 1000mg every 8 hours standing
* Oxycodone 5mg PO every 4 hours as needed pain
* Phenazopyridine 100mg TID as needed for urinary burning
* Senna 1 tab every 12 hours
* Miralax 17g powder once daily as needed for constipation

The standard of care group will get the following prescriptions on discharge:

* Oxycodone 5mg every 4 hours as needed pain - 15 tabs
* Acetaminophen 1000mg every 8 hours standing for two days then as needed
* Phenazopyridine 100mg TID as needed for urinary burning - 9 tabs
* Senna 1 tab every 12 hours - 10 tabs

Group Type NO_INTERVENTION

No interventions assigned to this group

Multi-modal group

The multi-modal group will receive the following regimen while inpatient:

* 2% topical lidocaine gel applied to catheter tip as needed for pain, maximum dose of 600mg in 12 hours
* Acetaminophen 1000mg every 8 hours standing
* Ibuprofen 600mg every 6 hours standing
* Oxycodone 5mg PO every 4 hours as needed pain
* Phenazopyridine 100mg TID as needed for urinary burning
* Senna 1 tab every 12 hours
* Miralax 17g powder once daily as needed for constipation
* Patient Education (Figures 2 \& 3)

The multi-modal group will receive the following prescriptions on discharge:

* Acetaminophen 1000mg every 8 hours standing for two days then as needed - 30 tabs
* Ibuprofen 600mg every 8 hours standing for two days then as needed - 30 tabs
* Phenazopyridine 100mg TID as needed for urinary burning - 9 tabs
* Senna 1 tab every 12 hours - 10 tabs

Group Type EXPERIMENTAL

Ibuprofen 600 mg

Intervention Type DRUG

We'll be adding ibuprofen while trying to limit oxycodone use while hospitalized. Patients will not be discharged with a narcotic.

Education

Intervention Type BEHAVIORAL

We'll be adding education to patient's post-operative instructions to aid in their pain control management.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ibuprofen 600 mg

We'll be adding ibuprofen while trying to limit oxycodone use while hospitalized. Patients will not be discharged with a narcotic.

Intervention Type DRUG

Education

We'll be adding education to patient's post-operative instructions to aid in their pain control management.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Are identified as candidates for TURP
* Are 18 years of age or greater
* Are proficient in English

Exclusion Criteria

* Have filled an opioid prescription in the last 2 months
* Have an allergy to a medication included in the protocol
* Have a history of pelvic radiation
* Have renal failure (Serum Cr \> 2.0 mg/dl), peptic ulcer disease, history of gastric bypass, cirrhosis, or other contraindication precluding use of NSAID's
* Have liver failure, hepatitis, or alcohol abuse which precludes use of acetaminophen
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Virginia Mason Hospital/Medical Center

OTHER

Sponsor Role collaborator

Benaroya Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Una Lee

Principal Investigator and Attending urologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Virginia Mason Medical Center

Seattle, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ryan Donahue, MD

Role: CONTACT

2062236600

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ryan Donahue, MD

Role: primary

512-484-3214

Una Lee, MD

Role: backup

2062236749

References

Explore related publications, articles, or registry entries linked to this study.

Alam A, Gomes T, Zheng H, Mamdani MM, Juurlink DN, Bell CM. Long-term analgesic use after low-risk surgery: a retrospective cohort study. Arch Intern Med. 2012 Mar 12;172(5):425-30. doi: 10.1001/archinternmed.2011.1827.

Reference Type BACKGROUND
PMID: 22412106 (View on PubMed)

Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Intern Med. 2016 Sep 1;176(9):1286-93. doi: 10.1001/jamainternmed.2016.3298.

Reference Type BACKGROUND
PMID: 27400458 (View on PubMed)

Hill MV, Stucke RS, McMahon ML, Beeman JL, Barth RJ Jr. An Educational Intervention Decreases Opioid Prescribing After General Surgical Operations. Ann Surg. 2018 Mar;267(3):468-472. doi: 10.1097/SLA.0000000000002198.

Reference Type BACKGROUND
PMID: 28267689 (View on PubMed)

Hill MV, McMahon ML, Stucke RS, Barth RJ Jr. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Ann Surg. 2017 Apr;265(4):709-714. doi: 10.1097/SLA.0000000000001993.

Reference Type BACKGROUND
PMID: 27631771 (View on PubMed)

Kose O, Saglam HS, Altun ME, Sonbahar T, Kumsar S, Adsan O. Prilocaine irrigation for pain relief after transurethral resection of the prostate. J Endourol. 2013 Jul;27(7):892-5. doi: 10.1089/end.2013.0001. Epub 2013 Jun 12.

Reference Type BACKGROUND
PMID: 23565930 (View on PubMed)

American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012 Feb;116(2):248-73. doi: 10.1097/ALN.0b013e31823c1030. No abstract available.

Reference Type BACKGROUND
PMID: 22227789 (View on PubMed)

Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.

Reference Type BACKGROUND
PMID: 26977696 (View on PubMed)

Maughan BC, Hersh EV, Shofer FS, Wanner KJ, Archer E, Carrasco LR, Rhodes KV. Unused opioid analgesics and drug disposal following outpatient dental surgery: A randomized controlled trial. Drug Alcohol Depend. 2016 Nov 1;168:328-334. doi: 10.1016/j.drugalcdep.2016.08.016. Epub 2016 Sep 20.

Reference Type BACKGROUND
PMID: 27663358 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB17-098

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enhanced Recovery After Urologic Surgery
NCT06789744 NOT_YET_RECRUITING NA
TAP Block for Open Radical Prostatectomy.
NCT01157546 TERMINATED PHASE1